Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108277
Status:
COMPLETED
Last Update Posted:
2015-01-19
First Post:
2005-04-14
Brief Title:
Respiratory Dysregulation and Breathing Training in Anxious Outpatients
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Respiratory Dysregulation and Breathing Training in Anxious Outpatients
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will explore respiratory dysregulation in anxious outpatients and examine the effect of breathing training with biofeedback for those anxious patients
Detailed Description:
In clinic testing and outside the clinic testing we will assess the prevalence of respiratory dysregulation in a sample of 60 non-psychotic not currently alcohol or drug abusing veteran outpatients from our MHC Mental Hygiene Clinic who experience episodic anxiety but who do not qualify and have never qualified for the diagnosis of PD panic disorder These patients will be compared to 30 patients who are not clinically anxious Of these 60 anxious patients 30 will be randomly assigned to a 4-week course of breathing training assisted by feedback of end-tidal pCO2 levels as an augmentation of their current treatment They will be compared to 30 who simply will continue with their current treatment TAU The breathing training group will receive clinical and physiological assessments immediately before the treatment period four weeks after the end of the treatment period and at a 4-month follow-up The TAU group will be assessed three times at equivalent intervals and if they wish may undergo breathing training after the third assessment Treatment will take place mainly in the first two years giving us adequate time for follow-up and data analysis We expect that this therapy will be especially effective for treating anxiety in the patients with substantial respiratory dysregulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None